GSK in talks to buy cancer biotech Nuvalent for more than $9 billion
By Reuters
·
2026-06-09
·
via Company News: Companies Analysis, Updates & Insights | The HinduBusinessLine
The deal comes at a time of biotech dealmaking frenzy, with large drugmakers on a spending spree to expand …
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。